Effects of eicosapentaenoic acid on left ventricular function in patients with nonischemic cardiomyopathy

Effects of eicosapentaenoic acid on left ventricular function in patients with nonischemic cardiomyopathy - Effects of eicosapentaenoic acid to nonischemic cardiomyopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013609

Enrollment

Registered

2014-04-02

Start date

2012-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure due to nonischemic cardiomyopathy

Interventions

Dose:EPA 1800mg Duration:6 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who agree a participation in this study by a document 2. Patients with chronic heart failure due to nonischemic cardiomyopathy 3. Patients who are more than 20-year-old and under 80-year-old

Exclusion criteria

Exclusion criteria: 1. Patients who are bleeding 2. Patients who are pregnant or have the possibility of pregnancy 3. Patients who are seemed to be difficult to participate in this study

Design outcomes

Primary

Measure	Time frame
physical sign biomarker left ventricular function	—

Countries

Japan

Contacts

Public ContactTakahiko Nishiyama

Keio University School of Medicine Cardiology

ntakahiko914@gmail.com03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026